Purpose: Using clinical administrative data (CAD) of inpatients, we aimed to identify ICD-10 codes coding for potentially preventable inhospital adverse drug events (ADE) that affect the length of hospital stay (LOS) and thus patient well-being and cost.
and Related Health Problems) have been identified and validated as ADE markers of high specificity both in retrospective and prospective analyses. [8] [9] [10] [11] [12] [13] However, the prospective investigation also revealed a rather low sensitivity of 6.8%. 13 This indicates a considerable underreporting of ADE in CAD and hence a limited usefulness of CAD because of their incompleteness or inaccuracy. Yet, screening of CAD might still detect more ADE than spontaneous reporting and the previously reported high specificity rates reflect a good coding quality for identified
ADE.
14,15 E.g. the Canadian ICD-10-CA system allows flagging ICD-10 codes that are present on admission. 9 This may help identifying hospital-acquired diagnoses that influence patient outcomes. 16 In Germany, it remains challenging to analyse inhospital ADE in CAD because German coding rules only define main and secondary diagnoses. Main diagnoses represent the main reason for hospitalisation. 7 Hence, if ADE coded as secondary diagnosis are assumed to occur during inhospital stay only, this may lead to a distorted picture of inhospital ADE burden. Furthermore, the influence of ADE on patients'
LOS might be of interest because exceeding a predefined upper limit of LOS means economic losses for the reimbursement of the respective patient cases. 17 This led us to check the suitability of CAD as a screening tool for potentially preventable inhospital ADE.
The aim of our study therefore was to (i) identify ADE coded in secondary diagnoses thereby assessing which ADE might occur during inhospital stay, and (ii) define a list of ICD-10 codes describing likely preventable inhospital ADE. Finally (iii), we investigated the association between potentially preventable inhospital ADE codes and LOS as a basis for choosing ADE codes worth to be validated as markers or as basis for the development of future prevention strategies.
| METHODS

| Study design and setting
In a retrospective analysis of CAD, we assessed ADE frequencies and patient characteristics from all adult inpatients of the University Hospital Heidelberg, Germany, in 2012 whose stays were covered by a German health insurance. We then quantified the impact of identified potentially preventable inhospital ADE on the LOS in a propensitymatched cohort design. To calculate the ratio of inpatients' LOS and the corresponding upper limit of LOS (LOS max ), as defined by the German coding rules, we had to exclude patient cases readmitted within 30 days which were counted as one case and inpatients with Diagnosis-Related Groups (DRG) where LOS or LOS max was zero or not defined. 18 The study protocol was approved by the responsible Ethics
Committee of the Medical Faculty of the University of Heidelberg.
| Clinical administrative data
Computerised, pseudonymised medical records were compiled into a 18 The ICD-10-GM (German Modification) of 2012 was used for coding.
| Identification of potentially preventable ADE codes
For ADE identification, we used a list of ICD-10 codes indicating an ADE according to the classification of Stausberg and co-workers.
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We adapted their classification and code selection to the ICD-10-GM version of 2012 by screening ICD-10 codes for the proposed definitions of categories A to C: Codes of category A and B implied that the event was directly related to a drug because it was explicitly mentioned in the code description: "caused by a drug" (A.1) or "caused by a drug or other substance" (A.2) and "poisoning by drug" (B.1) or "poisoning by or harmful use of a drug or other substance" (B.2). Codes of category C did not mention a drug in the code description but were rated as "ADE very likely" (see also Table 1) . 10 In total, we included 363 ICD-10 codes (Appendix S1, online material).
In a next step, encoders of departments with 5% or more inpatients with an ADE code were invited to specify ADE codes as occurring 'inhospital' in contrast to prior to admission. Therefore, only ADE codes of their own department were presented and no patient information was given. The answers were aggregated for each code and only ADE codes that were considered inhospital by 50% or more of encoders were included. Encoders were especially trained clinicians responsible for consistent and comprehensive encoding in their department or
What′s known
• It has been shown that ICD-10 codes in clinical administrative data can be used to identify ADE and patients with prolonged length of stay. However, current approaches in using routine data suffer from several shortcomings including the fact that routine data do not display the time the ADE was acquired (before or during hospitalisation) and, typically, the assessment does not account for actual preventability of ADE.
What′s new
• We now suggest a methodology to identify ICD-10 codes that reflect potentially preventable ADE and affect inpatients' length of stay (LOS).
• In a well-balanced propensity-matched cohort study, LOS was prolonged for inpatients with an ICD-10 code referring to a hospital acquired, preventable ADE.
• These findings now encourage further validation of the respective codes to tailor targeted prevention strategies for our hospital and to stimulate corresponding interventions in other settings.
other especially trained healthcare professionals working closely with clinicians, mainly appointed for the coding of diagnoses.
For preventability assessment, we focused on frequent ADE codes and thus concentrated on ADE codes coded at least as often as the median of all ADE codes (median=6; min=1, max=1 498 
| Influence on LOS
To investigate the relationship between ADE codes and LOS, we selected cases (inpatients with one or more ADE codes) and controls (inpatients without ADE code) by using Propensity Score (PS) matching. To compare the differently classified ADE codes, we allocated patients to three groups after matching: all patients with ADE codes, patients with an inhospital ADE code, and patients with a potentially preventable inhospital ADE code. To determine whether a prolonged LOS exceeded the maximum LOS (LOS max ) as defined for each DRG, 18 we calculated the ratio of LOS and LOS max (LOS/LOS max ).
| Statistical analyses
Clinical and demographic data were analysed to describe the patient cohort and calculate the influence of ADE codes on LOS. PS matching was conducted using logistic regression with a logit link function.
To account for relevant variables influencing the LOS, we included all relevant covariates accessible via CAD for our model. These were patients' age at admission, sex, Major Diagnostic Category, number of ICD-10 codes, discharging department, and the two comorbidity indices PCCL and Elixhauser index. 18, 21, 22 We applied a so-called greedy 3:1 nearest neighbour matching algorithm with exact matching for PCCL levels including sampling with replacement, allowing for excluding patient cases, and applying a caliper of 0.1. Balance was checked as proposed by common recommendations. 23, 24 Resulting PS weights were used in all subsequent weighted regression analyses. 25 Regression model selection was conducted with special emphasis to over-dispersion in likelihood ratio tests and investigation of standardised deviance residuals. 26 Accounting for missing zeros, we chose a zero-truncated negative binomial model with the NB2 algorithm. 27 Covariate selection included starting with a set of mandatory variables for adjustment (age, sex, PCCL and number of codes) and further assessment of significant contributions of interactions at the 0.05 significance level in a forward selection procedure. The resulting set of variables was also used to analyse the impact on LOS/LOS max . In these analyses, we used the binary indicator of exceeding LOS max in a logistic regression analysis. The log-transformed quotient LOS/LOS max was used in a linear regression analysis. Overall Wald tests were used to quantify the significance of main effects and their interactions with other covariates in common.
All tests were two-tailed, 95% confidence intervals (CI) were calculated, and P values < .05 were considered statistically significant.
Statistical analyses were performed using the R software/environment version 3.1.0 (R Foundation for statistical computing, Vienna, Austria). T A B L E 1 Distribution of ICD-10-GM codes in a population of patients hospitalised in 2012 in a German university hospital (N=54 032) and SPSS 22.0, 2013. All metric and normally distributed variables were reported as mean±standard deviation (SD), range and median.
Categorical variables were presented as frequency and percentage.
| RESULTS
| Patient characteristics and prevalence of ADE codes
A total of 54 032 patient cases were analysed with 48% (N=25 756)
females and a mean age of 57.8±18.3 years at admission. The mean LOS of the total population was 7.3±10.8 days (see also 
| Inhospital ADE codes and preventability
Out of 22 departments invited, encoders from 19 departments followed the invitation and assessed all ADE codes of their own department for their likelihood of being coded inhospital, leading to 128
(81.5%) ADE codes reviewed. Of these, 81 codes were frequently coded and 55 were rated as occurring inhospital with an overlap of 39 codes which were frequently coded and considered to be coded inhospital, relating to 79.5% (N=3 549) of all inpatients with an ADE code ( Figure 1 ). These ADE could be grouped into five categories 
| Influence on LOS
At total of 48 072 inpatient cases were suitable for evaluation.
Matching yielded 4 006 cases and 7 938 controls and showed wellbalanced groups with a mean age of 67 years (±17 years) and 43.8% female patients.
Adjusting for the strong predictors PCCL, the number of codes, and their interactions with the presence of ADE codes in multivariate regression models revealed a significant main effect of an ADE code to prolong the LOS (P=.048) and proved to be highly significant when simultaneously taking the interactions into account (Wald test: P<.001).
Using the model for prediction with median values of all variables
yielded a net increase of 1.13 days when an ADE code was present.
The relationship between ADE codes and the most influential variables PCCL and number of codes is visualised in Figure 3 , diagrams A and Subgroup analyses relied on the same modelling framework except interaction terms that were not significant. Patients with one or more out of the nine in clinical routine potentially preventable ADE codes (209 inpatients) had an increased risk for an additional day of 22% or a net increase of 1.88 days, respectively F I G U R E 2 Overview of preventability assessment of all frequently coded, as inhospital rated ADE codes. Rated as preventable…black, not preventable…hatched, no statement possible…?, and no information…white. From left to right: ADE code, 'theoretical' assessment based on Type of ADE reaction, summary of clinicians rating, individual clinicians' scores, number of patients with such ADE code, code description and ADE category. ADE codes deemed as potentially preventable in clinical routine are printed in bold italic type. ADE; Adverse drug event (Figure 3 , diagrams E, F). Also LOS/LOS max was significantly greater 
B. Considering inpatients' LOS/LOS
| DISCUSSION
| Identification of codes and prevalence
We identified 39 frequently coded ICD-10 codes that were considered as inhospital ADE and were associated with considerably longer LOS. Beside unspecific diagnosis codes, we found haematologic reactions caused by antineoplastic agents to be the most common inhospital ADE. This has also been observed in the UK, yet with differing ICD-10 codes (Y43.3, 92.1%). 28 An Australian study identified nausea and vomiting (R11, 5.5%), generalised skin eruption (L27, 4.9%), hypokalaemia (E87.6, 4.7%), and hypotension (I95.2, 4.7%) as most common inhospital ADE. 15 Yet, results referring to studies conducted in different countries with diverse healthcare settings are difficult to compare with ours, because setting, study population, the ICD coding framework and coding habits in each country differ.
Our overall prevalence rate of 8.3% is higher than previously found prevalence values (4.9%, 5.3%) using a similar ICD-10-based identification procedure. 5, 10 One important difference may be that coding quality has likely improved in recent years. While these earlier studies were performed before the German DRG-based reimbursement plan was fully implemented, our study covers a period in which coding quality was tightly linked to reimbursement. Furthermore, our hospital possibly puts even more emphasis on coding quality because it serves as one of the German reference hospitals for future DRG reimbursement adjustments.
29
F I G U R E 3 Predicted LOS for presence (dashed line) or absence (solid line) of an ADE code depending on the number of codes ( Figures 3A, 3C, 3E) , and PCCL values ( Figures 3B, 3D, 3F ) using median values (number of codes=10, PCCL=3) for all covariates in a zero-truncated negative binomial model. 3A and 3B: analysis for all inpatients with at least one ADE code vs. inpatients without ADE codes (control); 3C and 3D: subgroup analysis for all inpatients with at least one inhospital ADE code vs. control; 3E and 3F: Subgroup analysis for all inpatients with at least one inhospital ADE code rated as preventable in clinical routine vs. control
To identify inhospital ADE, we interviewed encoders because CAD do not provide information about the onset of ADE. Out of 55 inhospital ADE codes, only 13 (23.6%) had a 100% agreement between encoders. The diverse opinions for the same ADE code may reflect heterogeneities in patient populations and differing coding habits in individual departments. Therefore, the number of all inpatients with inhospital ADE codes must be interpreted with caution.
| Preventability
While different concepts to assess ADE preventability have been proposed, there is currently no satisfying approach, not least because of the incompleteness of information in this setting. 30, 31 Having a paper-based medication order system in our hospital, we relied on the limited information obtained by CAD and the rating of clinicians who were familiar with ICD-10 coding for preventability assessment. We chose the medications' mechanism of action, 19 and expert opinion to cover most suitable theoretical and clinical preventability assessment.
Focusing on the frequently coded ADE codes, we started the preventability assessment with the 39 codes predominantly rated as an inhospital event by encoders. Interrater-reliability between preventability assessment according to the type of ADE reaction and according to clinicians' expert opinion on the basis of ADE codes in their department was poor (kappa=0.14, Figure 2 ). This is likely because of the limited information given in the ICD-10 code description and the various clinical circumstances for which the same code can be used (eg, departmental circumstances, patient population, different specialties). For further analysis, we therefore relied on the nine ADE codes rated by clinicians as potentially preventable, assuming their rating more relevant for clinical practice than the preventability assessment by type of ADE reaction.
Thereby, the clinicians would often consider an ADE as inevitable even if its occurrence was theoretically avoidable. Moreover, in six cases, the clinicians rated the ADE as preventable, while on theoretical grounds an unequivocal assessment was not possible. The reasons for these differences are manifold: First, for most code descriptions the wording is rather vague without referring to a specific substance or drug group. In theoretical and clinical assessment, this led to 'no With only 29.3% of ADE allocated to type A or E reactions, the distribution according to the mechanism of action differed from a previous study where about 86% of ADE were categorised as type A and 0% as type E or F. 15 It is likely that our high fraction of ADE with 'no statement' (56.8%) contributed to this difference.
The clinicians' rating for preventability in clinical routine on the basis of ADE code descriptions led to nine ADE codes such as codes for drug-induced kidney injury or hypotension or complications following infusion, transfusion and therapeutic injection. This corresponds to 0.4% preventable inpatient cases in the entire cohort and 4.9% of all identified inpatients with ADE code (N=4 462). This is less than reported in prospective studies in hospitalised patients that used different ADE preventability assessments (20%-50%). 2, 3, [32] [33] [34] Reasons might be our retrospective design, which limits ADE identification because encoding ADE into CAD requires recognition and documentation of ADE in patient records in the first place. This, in turn, depends on the qualification of caregivers and severity of events, 35, 36 and might also be reimbursement triggered. 37 The limited information about ADE in CAD restricted the preventability assessment and our conservative approach. Using only ADE codes confirmed by a majority of asked encoders and clinicians might have also led to our low rate of potentially preventable ADE. Furthermore, in clinical routine ADE are often considered inevitable to achieve the treatment goal. But considering the significant underreporting of ADE in CAD, indicating a 14 times higher incidence as found in CAD, 13 these retrospectively identified nine preventable ADE codes represent the lowest common denominator in our hospital and are directive for future prevention strategies.
| Influence on LOS
Not all of the included ADE codes clearly link a symptom with a drug or a drug class, and hence, the inclusion of inpatients with such ADE codes into the case group might overestimate the effect of drugrelated adverse events. However, it was done in concordance with previous projects to enable comparison of results: In an earlier study evaluating the relationship between ADE codes and LOS in Germany, LOS was 2.9 days longer for patients with an ADE code when looking at the unadjusted arithmetic average of matched LOS values. 5 This is comparable to 3.0 days in our cohort. Nevertheless, we found a strong interdependence between the total number of ICD-10 codes, PCCL and ADE codes, which is why we conducted weighted regression analyses to adjust for these variables. With our model estimates, a patient with an ADE code and median values for all variables (number of codes=10, PCCL=3), would still have a net LOS increase of 1.13 days.
Also in both subgroup analyses, the LOS would be 0.88 days longer with an inhospital ADE code and 1.88 days longer with a preventable inhospital ADE code and exceeding LOS max substantially. This is important because any excess of LOS max immediately translates into financial losses of the hospital. The effect was largest for potentially preventable ADE codes stressing the need for targeted prevention strategies as an opportunity to prevent harm, improve care and efficiency.
| Limitations
The LOS is a value with multiple influencing variables, which cannot be covered completely by CAD. Hence, while our results are comparable with existing literature, findings need to be seen with caution.
The preventability assessment was subject to some uncertainties: Firstly, we need to mention our retrospective design and limited information provided by CAD which is why we relied on the experienced encoders' assessment of codes used for ADE occurring in the hospital. This is probably the best information source for data generated in their field of work but still subject to interindividual variability, This might allow for a more precise preventability assessment on a higher level than time-consuming patient record analysis.
| CONCLUSION
We developed a methodology to identify ICD-10 codes which reflect potentially preventable ADE occurring in a large university hospital. For patients with potentially preventable ADE code, LOS was prolonged by 1.88 days and exceeded the maximum hospital stay fully reimbursed by insurance companies (LOS max ), irrespective of their comorbidity.
These findings highlight that potentially preventable ADE codes need further validation to tailor targeted prevention strategies. These may improve care and avoid unnecessary long inpatient stays and should therefore be further analysed. Screening clinical administrative data for potentially preventable ADE codes can support the identification but needs to be interpreted in close clinical context. Further validation of identified ADE codes in patient records analysis will have to confirm their suitability as indicators for prevention strategies.
